The committee voted 21-0 that a new vaccine should focus on just one strain of the virus, and not be a bivalent shot as before. Any new vaccine should target one of three now prevalent in the U.S.: XBB.1.5, XBB.1.16 and XBB.2.3.
from WebMD Health https://www.webmd.com/covid/news/20230615/fda-panel-backs-new-covid-booster-focusing-only-on-variants?src=RSS_PUBLIC
0 Comments:
Post a Comment